Pfizer’s first quarter results drew a positive market response as management emphasized margin improvement and disciplined ...

Pharma companies met with the Trump administration earlier this month to try and defer implementation of the executive order ...

Pfizer CEO Albert Bourla, Ph.D., has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

Patrick T. Fallon/AFP/Getty Images via CNN Newsource CEO Dr. Albert Bourla says Pfizer has some "very real concerns" about new requirements for clinical trials of Covid-19 vaccines.

Britain faces paying more for US drugs as part of a deal to avoid future tariffs from Donald Trump. The NHS will review drug ...

Pfizer (PFE) and other drugmakers met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Pfizer CEO Albert Bourla said on Monday at the Goldman Sachs ...

Pfizer and other drug companies met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday. Alex Cohen has ...

The Health Secretary's attended the Bilderberg Meeting in Sweden, sipping champagne in the company of billionaires, bankers ...

CEO Dr. Albert Bourla says Pfizer has some "very real concerns" about new requirements for clinical trials of Covid-19 vaccines. Patrick T. Fallon/AFP/Getty Images via CNN Newsource; ...